2023
Risk of SARS‐CoV‐2 following joint and epidural corticosteroid injections: A retrospective study
Raju R, Holder E, Dundas M, Liang J, Donham R. Risk of SARS‐CoV‐2 following joint and epidural corticosteroid injections: A retrospective study. Pain Practice 2023, 24: 472-482. PMID: 37994676, DOI: 10.1111/papr.13321.Peer-Reviewed Original ResearchPCR positivity ratesCharlson Comorbidity IndexInjection groupPositivity rateCS injectionsControl groupCorticosteroid injectionSevere comorbiditiesPolymerase chain reaction positivitySARS-CoV-2 PCREpidural corticosteroid injectionsRetrospective chart reviewTertiary care centerCohort of patientsSignificant disease burdenCoronavirus disease 2019 (COVID-19) pandemicSignificant higher rateSARS-CoV-2Disease 2019 pandemicMultivariate regression analysisComorbidity indexPatients 18Chart reviewRetrospective studyImmunosuppressive effects
2018
Concomitant use of opioids and benzodiazepines in the outpatient setting: A retrospective study.
Simon J, Gehret J, Stolzenberg D, Beredjiklian P, Teng J, Paskey T, Raju R. Concomitant use of opioids and benzodiazepines in the outpatient setting: A retrospective study. PM&R 2018 PMID: 30243999, DOI: 10.1016/j.pmrj.2018.09.026.Peer-Reviewed Original ResearchPrescription drug monitoring programsOutpatient electronic medical recordsOutpatient settingConcomitant useNumber of opioidElectronic medical recordsOutpatient clinic visitsPatients prescribed opioidsAdministration of opioidsDrug monitoring programsClinic visitsMultiple providersCigarette/alcohol useBenzodiazepine prescriptionsOpioid related deathsRetrospective studyMedical recordsProvidersOpioidBenzodiazepinesPatientsRelated deathsPrescriptionMedicationPrescription(s